VERU INC. Accounts Receivable, before Allowance for Credit Loss
VERU INC. (VERU) had Accounts Receivable, before Allowance for Credit Loss of $6.72 million as of 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss
us-gaap:AccountsReceivableGross · last filed 2024-05-08
- 2024-03-31: Accounts Receivable, before Allowance for Credit Loss $6.72M.
- 2023-12-31: Accounts Receivable, before Allowance for Credit Loss $6.32M.
- 2023-09-30: Accounts Receivable, before Allowance for Credit Loss $8.45M.
- 2023-06-30: Accounts Receivable, before Allowance for Credit Loss $9.03M.
| Period end | Accounts Receivable, before Allowance for Credit Loss | Accounts Receivable, before Allowance for Credit Loss as first filed |
|---|---|---|
| 2024-03-31 | $6.72M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $6.32M 10-Q · filed 2024-04-01 | |
| 2023-09-30 | $8.45M 10-Q · filed 2024-05-08 | |
| 2023-06-30 | $9.03M 10-Q/A · filed 2023-11-15 | |
| 2023-03-31 | $8.14M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.89M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $4.29M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $9.76M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $9.79M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $8.17M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $8.94M 10-K · filed 2022-12-05 | |
| 2021-06-30 | $8.44M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $5.29M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $4.25M 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $5.33M 10-K · filed 2021-12-02 | |
| 2020-06-30 | $5.04M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $7.01M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $6.06M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $5.41M 10-K · filed 2020-12-10 | $5.10M 10-K · filed 2019-12-12 |
| 2019-06-30 | $4.84M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $4.08M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.56M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $4.05M 10-K · filed 2019-12-12 | |
| 2018-06-30 | $3.70M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $3.01M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $3.03M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $11.43M 10-Q · filed 2018-08-14 | |
| 2016-09-30 | $18.65M 10-K · filed 2018-01-02 | |
| 2015-09-30 | $14.14M 10-K · filed 2016-12-12 | |
| 2014-09-30 | $2.99M 10-K · filed 2015-12-02 | |
| 2013-09-30 | $2.38M 10-K · filed 2014-12-02 | |
| 2012-09-30 | $7.31M 10-K · filed 2013-12-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |